Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Steroids. 2017 Mar 10;121:17–21. doi: 10.1016/j.steroids.2017.03.001

Table 1.

Participant Characteristics

Premenopausal n=23 Postmenopausal n=22
Age (yr) 42 ± 4 55 ± 4*
Years since menopause n/a 7 ± 6
Weight (kg) 67.6 ± 8.4 62.1 ± 8.2
BMI (kg/m2) 24.2 ± 2.5 23.3 ± 2.4
%fat 33.3 ± 4.8 34.5 ± 5.2
Total Fat Mass (kg) 22.7 ± 5.3 21.7 ± 5.3
Trunk Fat Mass (kg) 9.2 ± 2.6 9.7 ± 3.5
Leg Fat Mass (kg) 10.4 ± 2.5 8.8 ± 1.7*
Fat-free mass (kg) 44.9 ± 4.6 40.5 ± 4.7*
VFA 41 ± 25 58 ± 41
Abdominal SFA (cm2) 229 ± 62 221 ± 71
Femoral SFA (cm2) 212 ± 58 173 ± 40*
Femoral IMFA (cm2) 17 ± 9 15 ± 6
Estradiol (pg/mL) 91 ± 76 13 ± 6
Leptin (ng/mL) 13 ± 6 12 ± 8
*

p<0.05; mean±SD; VFA = visceral fat area;

SFA = subcutaneous fat area, IMFA = intra-muscular fat area.